Perrigo is continuing to revitalize the UK's sleep aid category with a Liquid Caramel line extension to its successful Nytol brand. 

Private-label OTC brands are increasingly popular with German consumers, according to McKesson Europe. To take advantage of this trend, the retailer is through its Gehe German subsidiary extending its "healthy living" line of own-brand OTC products. 

Research from Euromonitor International reveals how consumers globally are struggling with stress and anxiety and are turning away from conventional drugs in favor of lifestyle changes. With consumers now ranking mental well-being as their number-one health priority, OTC players must adopt a more holistic approach to healthcare or risk being left behind. 

Germany's OTC market through pharmacy performed disappointingly in the first six months of the year thanks to a weak cold season compared to the previous year, according to IQVIA. 

GSK's proposed usage for mouth spray product – reducing withdrawal symptoms, including nicotine craving – differs little from the first NRT product approved in US in 1984. Additional suggested label instructions primarily focus on stating NRTs can be used to reduce smoking or gradually stop tobacco use as opposed to quitting within a specified amount of time.

Attorneys are warning CBD product marketers to be on guard for litigation challenging the authenticity of their claims, the safety of their products and other aspects of their businesses. So far, suits of this nature have been limited in the US, but the few known cases could be harbingers of a larger wave to come.

UK's Advertising Standards Authority tells Cambridge Chocolate to halt ad claims for Esthechoc functional chocolate after firm fails to sway experts with multiple studies on astaxanthin and epicatechins, ingredients in chocolate it says science has shown have a beneficial impact on skin.

Amid global recession fears, Lauder anticipates continued double-digit growth in fiscal 2020 in China and travel retail, albeit at slower rates than seen in recent years. The firm booked 9% reported sales growth to roughly $14.9bn for the fiscal 2019 full year, fueled by a record-setting innovation program.

Launches announced in August include Clarisonic Mia Men, the brand’s first cleansing device specifically engineered for men’s thicker skin and beard, and Act Of Being, touted as “America’s first 100% vegan men’s grooming and skin-care brand.” Fragrances from Ariana Grande and Vince Camuto debut, along with Moroccanoil Color Depositing Masks and Avon Products’ True 5-in-1 Lash Genius mascara.

Personal Care Products Council exec Tom Myers says it’s crucial that industry be involved now, ahead of proposed rulemaking expected from California’s “clean air agency” in 2020, to inform the Air Resources Board about reformulation challenges and opportunities to reduce levels of volatile organic compounds in line with state goals.

Hairburst’s hair-growth and hair-loss prevention claims on cosmetic products are inadequately substantiated, and many of the health claims it uses to promote food supplements are unauthorized, the Advertising Standards Authority says in a 14 Aug. decision.

Attorneys are warning CBD product marketers to be on guard for litigation challenging the authenticity of their claims, the safety of their products and other aspects of their businesses. So far, suits of this nature have been limited in the US, but the few known cases could be harbingers of a larger wave to come.

Seeking to end the current impasse between regulators and the CBD industry, the Centre For Medicinal Cannabis is launching a quality charter for its members to put their products “on the path to regulatory compliance.” 

UK's Advertising Standards Authority tells Cambridge Chocolate to halt ad claims for Esthechoc functional chocolate after firm fails to sway experts with multiple studies on astaxanthin and epicatechins, ingredients in chocolate it says science has shown have a beneficial impact on skin.

Research from Euromonitor International reveals how consumers globally are struggling with stress and anxiety and are turning away from conventional drugs in favor of lifestyle changes. With consumers now ranking mental well-being as their number-one health priority, OTC players must adopt a more holistic approach to healthcare or risk being left behind. 

Research from Euromonitor International reveals how consumers globally are struggling with stress and anxiety and are turning away from conventional drugs in favor of lifestyle changes. With consumers now ranking mental well-being as their number-one health priority, OTC players must adopt a more holistic approach to healthcare or risk being left behind. 

Germany's OTC market through pharmacy performed disappointingly in the first six months of the year thanks to a weak cold season compared to the previous year, according to IQVIA. 

An analysis by Sempora Consulting of the German OTC market in 2018 shows that generic products dominate new OTC product launches.